drug · Product Intelligence

Centanafadine
Pipeline Intelligence

Centanafadine: 6 indexed trials, 1 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
6Indexed trials
▦
1Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT04786730Otsuka Pharmaceutical Development & Commercialization, Inc. · adhdPHASE1
NCT05113953Otsuka Pharmaceutical Development & Commercialization, Inc. · eating_disordersPHASE2
NCT05536414Otsuka Pharmaceutical Development & Commercialization, Inc. · depressionPHASE2
NCT06973577Otsuka Pharmaceutical Development & Commercialization, Inc. · adhdPHASE3
NCT07314333Otsuka Pharmaceutical Development & Commercialization, Inc. · adhdPHASE1
NCT07486895Otsuka Pharmaceutical Development & Commercialization, Inc. · adhdPHASE1

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.